Airway Malacia: Stent Innovations and Emerging Ex Vivo Testing Platforms

Area of Science:

• Biomedical Engineering
• Respiratory Medicine
• Materials Science

Background:

• Tracheobronchomalacia (TBM) is a benign condition causing airway collapse due to weakened airway walls.
• Current treatments for TBM include continuous positive airway pressure (CPAP) and surgery, with airway stents offering an intermediate option.
• Existing airway stents face limitations for long-term use, including granulation tissue formation and impaired mucociliary clearance.

Purpose of the Study:

• To explore the potential of optimally designed helical stents for treating tracheobronchomalacia.
• To identify solutions for complications associated with long-term stent implantation.
• To highlight the need for standardized stent-testing platforms.

Main Methods:

• Review of existing treatment modalities for TBM.
• Investigation of helical stent designs using metallic and non-metallic materials.
• Evaluation of ex vivo tissue-based platforms for stent testing.

Main Results:

• Helical stents show potential for addressing complications like granulation tissue and mucociliary clearance issues.
• Optimally designed stents could be suitable for long-term implantation in TBM patients.
• Progress in ex vivo platforms offers a path for robust airway stent development and testing.

Conclusions:

• Helical stents represent a promising avenue for improving TBM management.
• Development of novel stent designs and standardized testing platforms is essential.
• Ex vivo tissue models are critical for advancing airway stent technology.